We are studying the effects of HRO761 in cancer patients with certain DNA alterations known as Microsatellite Instability-High or Mismatch Repair Deficiency. This trial will help us understand how well this treatment works alone and with other therapies.
Health conditions and diseases that the clinical trial is designed to study and treat.
Microsatellite instability (MSI) is a condition where the DNA repair process is faulty, leading to an increased risk of certain cancers, particularly in advanced or metastatic solid tumors. Mismatch repair cancer syndrome refers to a group of cancers that arise due to defects in the DNA mismatch repair system.
Locations and medical facilities where this clinical trial is currently recruiting or conducting research. Select the locations where you would like to participate.
Disclaimer: Parts of this content have been automatically extracted from the EU Clinical Trials registry. While we strive for accuracy, please always contact the trial site or sponsor directly for correct and official information before making any decisions about participation. View on EU Clinical Trials.
